At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
Location: United Kingdom, England, Cambridge
Total raised: $103M
Investors 3
| Date | Name | Website |
| - | b2venture | b2venture.... |
| - | Ruttenberg... | ruttenberg... |
| 23.07.2023 | VU Venture... | vuventurep... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.08.2024 | Series C | $47M | - |
| 16.10.2019 | Series B | $56M | - |
Mentions in press and media 6
| Date | Title | Description |
| 08.08.2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| 02.08.2024 | Healx announces $47 million Series C financing and FDA clearance of phase 2 IND for Neurofibromatosis type 1 trial | Cambridge, UK – Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, announced it has raised $47 million in a Series C round. Series C round co-led by R42 Group and Atomico, and joined by new/current investors... |
| 02.08.2024 | Healx Raises $47M in Series C Financing | Healx, a Cambridge, UK-based AI-enabled, clinical-stage biotech company specializing in rare diseases, raised $47m in Series C funding. The round was co-led by R42 Group and Atomico, with participation from new and existing investors includ... |
| 03.06.2024 | Кто будет разрабатывать лекарства? | Появление новых лекарств — всегда ожидаемое событие. Несмотря на широкомасштабные исследования фармкомпаний эффективных средств по–прежнему не хватает. В среднем на разработку одного препарата уходит 10–15 лет и около 2,5 млрд долларов — эт... |
| 11.04.2024 | Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments | Cambridge, UK - Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, announces that it has signed an investment agreement with its long-term partner, Children’s Tumor Foundation (CTF). M... |
| 13.04.2023 | Preventing the Next Pandemic: The Innovative Solutions Leading the Way | The COVID-19 pandemic created an unprecedented health and societal crisis for many of us across the world. Its death toll estimates place it among history’s deadliest plagues. Despite having much more advanced economic, healthcare, and tech... |